Program Overview

In September 2010, the United States Agency for International Development (USAID) awarded FHI 360 two five-year Control of Neglected Tropical Diseases (NTD) Cooperative Agreements spanning both Africa and Asia and marking the beginning of track two of USAID’s NTD control program. Subsequently, END in Africa received a 3-year extension, running through September 2018.

Building on the foundations of the program’s first track, FHI 360 launched the END in Africa and in Asia programs in October 2010. The programs support national health ministries and other government entities in Africa and Asia as they scale up their local integrated NTD control activities.

As the primary partner for the END programs, FHI 360 provides overall program and financial management, coordination, and quality control. Its partners provide capacity building in financial management, drug forecasting and supply chain management, program monitoring and evaluation, and knowledge management. FHI 360 has also engaged several sub-grantees to assist the countries in coordinating local program activities.

FHI 360 and its partners have close relationships with governments and nongovernmental organizations in Asia and Africa, a wealth of experience developing global and country-level infrastructure, and the staff and systems to ensure a rapid start-up and a smooth expansion of effective preventive chemotherapy and support activities for NTDs. The FHI 360-led team’s strategic and technical approach capitalizes on each partner’s strengths and emphasizes country ownership, collaboration, transparency, accountability, and sustainability.

Key Program Elements

  • Increasing country ownership by ensuring active government participation in program activities, improving communication with government stakeholders, and closely targeting resources to support MOHs as they integrate disease control and the delivery of preventive chemotherapy into national strategic plans.
  • Supporting the integration of vertical NTD control programs through the co-management of diseases to increase cost efficiencies, treat more individuals and improve program sustainability.
  • Fostering collaboration among a wide range of stakeholders—brought together through effective Intra-Country Coordinating Committees (ICCCs)—to strengthen integration, achieve cost efficiencies, and maximize the impact of resources.
  • Ensuring transparency and accountability through grant-making and management built on clearly defined roles and responsibilities, transparent systems, processes and procedures, open communication, and the regular sharing of data, results, and lessons learned.
  • Building long-term sustainability by working with MOHs, Neglected Tropical Disease Control Programs (NTDCPs) and other country-level entities and programs in a way that strengthens national systems and capacity to deliver integrated programming.

Program at a Glance

Countries: Burkina Faso, Cote d’Ivoire, Ghana, Niger, Sierra Leone, and Togo

Diseases: lymphatic filariasis (elephantiasis), onchocerciasis (river blindness), schistosomiasis (snail fever), trachoma (blinding eye infection) and three soil-transmitted helminths (hookworm, roundworm, and whipworm)

Duration: 2010 – 2018

Results of END in Africa in 2011-2013: almost 217 million treatments delivered, almost 95 million people treated, >175,000 people trained

Partners and sub-grantees: National Ministries of Health, FHI 360 (lead), Deloitte Consulting LLP, Helen Keller International, Health and Development International,

Projected Number of people and health districts to be treated in FY2013

Persons DIST Persons DIST Persons DIST Persons DIST Persons DIST
Burkina Faso 10,515,082 47 1,026,899 6 4,396,381 20 2,536,628 12* 4,562,653 52
Ghana 7,559,578 70 2,386,078 51 5,066,184 170 NA NA 6,859,637 170
Niger 9,931,544 30 NA NA 1,830,852 11 8,319,387 18 13,244,426 34
Sierra Leone 5,776,290 14 2,564,958 12 1,709,510 7 NA NA 5,776,290 14
Togo NA NA 2,628,726 32 1,933,315 33 NA NA 1,713,484 28
Total 33,782,494 161 8,606,661 101 14,936,242 241 10,856,015 30 32,156,490 298

* Provision of PCT drugs for trachoma is contingent upon the implementation of the SAFE strategy in addition to the existing “A” (antibiotics) component in 4 districts

LF Lymphatic filariasis; Oncho Onchocerciasis; SCH Schistosomiasis; STH Soil-transmitted helminthes; DIST Districts; NA not applicable because the country is no longer endemic for that disease.

Program News

Number of people to be treated for at least one NTD in FY2015

Over 69.1 million*

*Individuals may be counted more than once if receiving treatment for more than one NTD

Photo Credit: Helen Keller International


Twitter: ENDinAfrica